Recent Quotes View Full List My Watchlist Create Watchlist Indicators DJI Nasdaq Composite SPX Gold Crude Oil EL&P Market Index Markets Stocks ETFs Tools Overview News Currencies International Treasuries Xoma Royalty Corporation (NQ: XOMA ) 30.86 +0.48 (+1.58%) Streaming Delayed Price Updated: 4:00 PM EST, Nov 4, 2024 Add to My Watchlist Quote Overview Detailed Quote Charting Historical Prices News All News News Headlines Press Releases Research Quarterly Reports Insider Filings Other Filings Headline News about Xoma Royalty Corporation < Previous 1 2 Next > XOMA Stock Earnings: XOMA Misses EPS, Beats Revenue for Q2 2024 August 13, 2024 XOMA stock results show that XOMA missed analyst estimates for earnings per share but beat on revenue for the second quarter of 2024. Via InvestorPlace FDA Convenes Expert Panel Meeting For Zevra Therapeutics' Arimoclomol, Analyst Optimistic About Approval Despite Small Patient Base July 09, 2024 FDA's Genetic Metabolic Diseases Advisory Committee will review Zevra Therapeutics' arimoclomol for Niemann-Pick disease type C on August 2. PDUFA decision expected by September 21. Via Benzinga Exposures Product Safety Demystifying XOMA: Insights From 5 Analyst Reviews July 09, 2024 Via Benzinga 3 Crazy Good Stocks to Buy With $500 Right Now June 12, 2024 For investors with only a little money to spare, these three supercharged stocks represent an outrageous opportunity for future growth. Via InvestorPlace Peeling Back The Layers: Exploring XOMA Through Analyst Insights May 31, 2024 Via Benzinga XOMA Stock Earnings: XOMA Misses EPS, Beats Revenue for Q1 2024 May 09, 2024 XOMA stock results show that XOMA missed analyst estimates for earnings per share but beat on revenue for the first quarter of 2024. Via InvestorPlace Cracking The Code: Understanding Analyst Reviews For XOMA April 29, 2024 Via Benzinga Recap: XOMA Q4 Earnings March 08, 2024 Via Benzinga XOMA's Return On Capital Employed Insights May 24, 2023 Via Benzinga XOMA Stock Earnings: XOMA Misses EPS, Misses Revenue for Q4 2023 March 08, 2024 XOMA stock results show that XOMA missed analyst estimates for earnings per share and missed on revenue for the fourth quarter of 2023. Via InvestorPlace Biotech Royalty Aggregator XOMA To Acquire Small Cancer-Drug Developer Kinnate Biopharma February 16, 2024 XOMA acquires Kinnate Biopharma for $2.3352 per share, with potential additional cash. The acquisition is expected to close in April 2024. Via Benzinga Stocks That Hit 52-Week Lows On Friday September 01, 2023 On Friday, 57 companies reached new 52-week lows. Via Benzinga XOMA Earnings Perspective: Return On Capital Employed March 15, 2023 Via Benzinga XOMA's Return On Capital Employed Insights November 24, 2022 Via Benzinga Starbucks And 3 Other Stock Insiders Are Buying September 19, 2022 Although US stocks closed lower on Friday, there were a few notable insider trades. Via Benzinga Recap: XOMA Q4 Earnings March 08, 2022 XOMA (NASDAQ:XOMA) reported its Q4 earnings results on Tuesday, March 8, 2022 at 07:30 AM. Here's what investors need to know about the announcement. Earnings XOMA... Via Benzinga Stocks That Hit 52-Week Lows On Monday August 28, 2023 During Monday, 102 stocks hit new 52-week lows. Via Benzinga Stocks That Hit 52-Week Lows On Thursday July 27, 2023 During Thursday, 56 stocks hit new 52-week lows. Via Benzinga Arimoclomol and Aldoxorubicin Acquisition to Bolster XOMA's Revenue Growth: Analyst June 22, 2023 Earlier today, XOMA Corporation (NASDAQ: XOMA) acquired the royalty and milestone rights associated with two assets from LadRx Corporation: arimoclomol for Niemann-Pick disease type C, and... Via Benzinga Stocks That Hit 52-Week Lows On Wednesday July 26, 2023 Wednesday saw 59 companies set new 52-week lows. Via Benzinga Recap: XOMA Q1 Earnings May 09, 2023 XOMA (NASDAQ:XOMA) reported its Q1 earnings results on Tuesday, May 9, 2023 at 07:30 AM. Here's what investors need to know about the announcement. Earnings XOMA missed estimated earnings by 96.0%,... Via Benzinga XOMA: Q1 Earnings Insights May 09, 2023 XOMA (NASDAQ:XOMA) reported its Q1 earnings results on Tuesday, May 9, 2023 at 07:30 AM. Here's what investors need to know about the announcement. Earnings XOMA missed estimated earnings by 96.0%,... Via Benzinga XOMA: Q3 Earnings Insights November 03, 2022 XOMA (NASDAQ:XOMA) reported its Q3 earnings results on Thursday, November 3, 2022 at 07:45 AM. Here's what investors need to know about the announcement. Earnings XOMA missed estimated earnings by... Via Benzinga Stocks That Hit 52-Week Lows On Thursday September 08, 2022 On Thursday, 168 companies reached new 52-week lows. Via Benzinga XOMA Earnings Perspective: Return On Capital Employed May 27, 2022 Benzinga Pro data, XOMA (NASDAQ:XOMA) reported Q1 sales of $3.11 million. Earnings fell to a loss of $2.28 million, resulting in a 107.64% decrease from last quarter. In Q4, XOMA earned $29.84 million,... Via Benzinga XOMA's Return On Capital Employed Insights March 10, 2022 According to Benzinga Pro, during Q4, XOMA (NASDAQ:XOMA) earned $29.84 million, a 772.77% increase from the preceding quarter. XOMA also posted a total of $35.94 million in sales... Via Benzinga 50 Biggest Movers From Yesterday January 06, 2022 Gainers Lixte Biotechnology Holdings, Inc. (NASDAQ: LIXT) shares surged 63.7% to settle at $2.21 on Wednesday after the company announced that in preclinical studies its lead... Via Benzinga Stocks That Hit 52-Week Lows On Wednesday May 04, 2022 During Wednesday's trading, 435 companies set new 52-week lows. Via Benzinga 12 Health Care Stocks Moving In Wednesday's Intraday Session January 05, 2022 Gainers Lixte Biotech Holdings (NASDAQ:LIXT) stock increased by 70.4% to $2.3 during Wednesday's regular session. Trading volume for this security as of 12:31 EST is... Via Benzinga XOMA's Return On Capital Employed Overview November 08, 2021 Benzinga Pro data, XOMA (NASDAQ:XOMA) reported Q3 sales of $940.00 thousand. Earnings fell to a loss of $3.35 million, resulting in a 9.17% decrease from last quarter. In Q2,... Via Benzinga < Previous 1 2 Next > Data & News supplied by www.cloudquote.io Stock quotes supplied by Barchart Quotes delayed at least 20 minutes. By accessing this page, you agree to the following Privacy Policy and Terms and Conditions.
